Biotech Spotlight: Page 3
-
Q&A // Biotech Spotlight
Biotech Spotlight: Everest Medicines takes aim at unmet needs in Asia
With a multi-pronged business strategy, Everest Medicines is positioning itself as a ‘rising force’ in Asian biotech.
By Taren Grom • May 9, 2022 -
Q&A // Biotech Spotlight
How OliX Pharmaceuticals is riding the RNAi wave
While the company may look like “the new kid on the block,” CEO Dong-ki Lee says the Korean biotech is ready for the global stage.
By Karissa Waddick , Taren Grom • April 25, 2022
To find more content, use the "Topics" in the menu above.